Rockland boosts life sciences portfolio with purchase of antibody line

21st Century Biochemicals agreed to sell its line of Epi-Plus antibodies, which are used in epigenetic studies, to Rockland Immunochemicals. The price was not disclosed. The deal will bolster Rockland's life science tools portfolio. The Epi-Plus brand is co-owned by Novus Biologicals.

View Full Article in:

Genetic Engineering & Biotechnology News · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Quality Regulatory Affairs
Cardinal Health
Chicago, IL
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC